Overview
Heidi Health, based in Melbourne, Australia, has raised $65M in a Series B round on Oct 6, 2025, with participation from Point72 Ventures. The company independent, unlimited clinical answers. The round will be used to accelerate product development, expand the team, and scale go-to-market operations.
Operating in the software development sector, Heidi Health is positioned to capitalize on growing demand for innovative solutions in this space. The company was founded in 2021 by Thomas Kelly. Thomas brings deep domain expertise and a track record of execution that attracted investor confidence in this round. With fresh capital, the company is expected to invest heavily in R&D and talent acquisition, signaling a period of aggressive growth ahead.
Market Outlook
This funding positions Heidi Health as one to watch in the software development landscape. As the company scales, it will likely become an increasingly attractive partner — and customer — for B2B vendors looking to sell into well-funded, growth-stage companies. The post-raise window of 60-90 days is typically when startups are most receptive to new tools, services, and partnerships.
Why contact Heidi Health now
Heidi Health just closed $65M in Series B funding — which means they're actively scaling their team, upgrading their tech stack, and looking for vendors who can help them move fast. Companies at this stage typically make purchasing decisions within 60-90 days of closing a round. If you sell to software development companies, this is your window to reach out before competitors do.
Founders & Contacts
Investors
Company Facts
| Company | Heidi Health |
| Amount Raised | $65M |
| Funding Round | Series B |
| Date Raised | Oct 6, 2025 |
| Founded | 2021 |
| Industry | Software Development |
| Founders | Thomas Kelly |
| HQ Location | Melbourne, Australia |
Get Verified Founder Emails
Access verified email addresses and contact details for Heidi Health's founders and thousands of other funded startups.
Start Free Trial